Production (Stage)
COSCIENS Biopharma Inc.
CSCI
$3.68
$0.113.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 464.00K | 464.00K | 1.03M |
| Total Depreciation and Amortization | -- | -- | 2.10M | 2.10M | 2.08M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -2.85M | -2.83M | -862.00K |
| Change in Net Operating Assets | -- | -- | 2.28M | 2.28M | 335.00K |
| Cash from Operations | -- | -- | 1.98M | 2.00M | 2.58M |
| Capital Expenditure | -- | -- | -1.44M | -1.44M | -1.34M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 26.04M | 26.04M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -8.00K | -8.00K | -8.00K |
| Cash from Investing | -- | -- | 24.59M | 24.59M | -1.34M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -488.00K | -510.00K | -454.00K |
| Issuance of Common Stock | -- | -- | 13.00K | 13.00K | 13.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -475.00K | -497.00K | -441.00K |
| Foreign Exchange rate Adjustments | -- | -- | -59.00K | -58.00K | 189.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 26.04M | 26.04M | 984.00K |